AUS
NZ
UK
CA
USA
IND
Healthcare
Livium Clears Lind Facility Repayments Following $4.5M Capital Injection
March 13, 2025 12:05 PM AEDT| By Team Kalkine MediaHighlights,Livium,(,ASX:LIV,) completes full repayment of Lind Facility.,No new shares issued as part of the settlement.,Institutional and sophisticated investors contribute A$4.5 million.,Livium Ltd (ASX:LIV) has successfully finalized all necessary...
Revolutionizing Diabetes Care: (ASX:PIQ) Unveils Promarker®D Test to Predict Kidney Disease Risk
March 13, 2025 11:58 AM AEDT| By Team Kalkine MediaHighlights,Advanced Diagnostic Tool:,Promarker®D,predicts chronic kidney disease up to four years in advance.,Nationwide Availability:,Initial rollout in Western Australia and the Northern Territory, with plans to expand across Australia.,Global Expa...
Avecho Biotechnology Reports Strong Revenue Growth Amid Share Price Decline
March 13, 2025 11:31 AM AEDT| By Team Kalkine MediaHighlights:,Revenue experienced a substantial increase compared to the previous fiscal period.,A decline in net loss reflects an improvement in financial performance.,Share value moved lower over the past week.,Avecho Biotechnology (ASX:AVE) , operat...
Health Check: Celebrate the Diligent Bodily 'Spuds' on World Kidney Day
March 13, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Proteomics International Laboratories launched Promarker D in Australia for diabetic kidney disease detection.,Dimerix continues progress in a late-stage trial for a focal glomerulosclerosis treatment.,Trivarx collaborates with the US Vet...
Emerging Trends in ASX Pharmaceuticals: Commercialization and Telehealth Initiatives
March 13, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlight,ASX pharmaceutical companies focus on retaining assets longer for direct commercialization.,LTR Pharma is leveraging telehealth for its novel nasal spray market expansion.,Botanix Pharmaceuticals pursues independent US commercialization wit...
CurveBeam AI (ASX:CVB) is Utilizing a Moderate Level of Debt
March 12, 2025 03:30 PM AEDT| By Team Kalkine MediaHighlights:,CurveBeam AI operates within the medical technology sector, focusing on advanced imaging solutions.,The company holds a notable level of debt, with financial obligations exceeding available liquid assets.,Revenue decline and operational l...
Telix Pharmaceuticals (ASX:TLX) Strengthens Cancer Pipeline with FAP-Targeting Acquisition
March 12, 2025 02:38 PM AEDT| By Team Kalkine MediaHighlights,Strategic Expansion:,Telix,Pharmaceuticals (,ASX:TLX,) enhances its nuclear medicine pipeline.,New,Theranostic,Focus:,Addition of TLX400 advances bladder cancer and pan-cancer applications.,Global Potential:,Clinically validated radiopharm...
Healthcare Stocks to Watch: A Look at (ASX:SHL) and (ASX:PME) in 2025
March 12, 2025 01:12 PM AEDT| By Team Kalkine MediaHighlights,Sonic Healthcare,has seen a decline of 6.2% since the start of 2025, while (,ASX:PME,),remains,25.7% below its 52-week high.,Sonic Healthcare is a global leader in pathology and diagnostic services, serving multiple regions.,Pro Medicus sp...
Beamtree Holdings Limited Faces a Challenging Period
March 11, 2025 07:35 PM AEDT| By Team Kalkine MediaHighlights,Beamtree Holdings Limited (ASX: BMT) shares slump by 28% over the past month.,Company's Price-to-Sales ratio is low compared to industry standards.,Revenue growth forecasts trail the industry expectations significantly.,In recent weeks, Be...
Cyclopharm Limited (ASX:CYC): Navigating a Challenging Month
March 11, 2025 07:34 PM AEDT| By Team Kalkine MediaHighlights,Cyclopharm's stock saw a 38% decline over the past month.,Current price-to-sales (P/S) ratio stands at 5.6x.,Future growth seen at 50% annually over the next three years.,Cyclopharm Limited (ASX:CYC) has recently experienced a challenging...
Investors drive Mesoblast (ASX:MSB) down by 18% this week, potentially due to the company's rising losses.
March 11, 2025 07:32 PM AEDT| By Team Kalkine MediaHighlights:,Mesoblast Limited has experienced significant stock price movement, with a notable increase over the past year.,A recent decline contrasts with long-term gains, prompting further examination of revenue trends and market sentiment.,Insider...
ECS Botanics Holdings (ASX:ECS): A Deeper Dive into the P/S Ratio
March 11, 2025 07:30 PM AEDT| By Team Kalkine MediaHighlights,ECS Botanics Holdings (ASX:ECS) displays a low price-to-sales (P/S) ratio.,Investors show concerns over declining revenue trends.,Potential for future growth remains uncertain amid industry comparisons.,For those eyeing the pharmaceutical...
PolyNovo (ASX:PNV) Embarks on Leadership Transition: CEO Steps Down
March 11, 2025 02:32 PM AEDT| By Team Kalkine MediaHighlights,Leadership Change:,CEO Swami,Raote,steps down,immediately,; interim CEO appointed.,Board Review:,Governance and succession planning in focus.,CEO Remuneration:,Salary and share details,disclosed,.,PolyNovo (ASX:PNV) has announced a signifi...
EZZ Life Sciences Experiences Decline as It Expands Manufacturing Operations into the US.
March 11, 2025 02:32 PM AEDT| By Team Kalkine MediaHighlights,EZZ Life Sciences (ASX:EZZ) enters the U.S. market with local manufacturing operations.,Strategic partnership with GLSP ensures compliance with FDA and international standards.,Market response reflects cautious investor sentiment amid econ...
4DMedical (ASX:4DX) Secures Multi-Year Contract Extension with Cleveland Clinic, Strengthening Market Position
March 11, 2025 01:08 PM AEDT| By Team Kalkine MediaHighlights,4DMedical (ASX:4DX) renews a three-year contract with Cleveland Clinic.,Agreement,ensures continued growth in revenue per site.,Strengthened positioning in respiratory imaging technology.,4DMedical (ASX:4DX) has successfully secured a thre...
Dr. Boreham's Crucible: This Company Targeting a Rare Blood Disease Aims to Impress Investors with Its Strongest Effort
March 11, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Syntara shifts from its Bronchitol program to advancing treatments for myelofibrosis.,Phase I/IIa trial data for SNT-5505 indicates effectiveness with improved tolerability.,Strategic restructuring aligns with expanded research initiative...
Big Changes in ASX 50: Pro Medicus and Sigma Healthcare Join, Mineral Resources and Ramsay Exit
March 10, 2025 01:20 PM AEDT| By Team Kalkine MediaHighlights,Pro Medicus (,ASX:PME,) and Sigma Healthcare (,ASX:SIG,),set,to join ASX 50.,Mineral Resources (,ASX:MIN,) and Ramsay Health Care (,ASX:RHC,) to exit the index.,Changes to ASX 100 and ASX 200 indices announced, effective March 24.,The late...
PolyNovo Shares Rebound After Addressing Allegations Against Chair
March 10, 2025 12:22 PM AEDT| By Team Kalkine MediaHighlights:,Share Movement:,PolyNovo shares climbed 3.8% after falling 13% on Friday.,CEO Departure:,The company confirmed CEO Swami Raote's exit amid reports of a bullying probe involving the chair.,Governance Measures:,PolyNovo has brought in legal...
PolyNovo Shares Surge as Governance Measures Reassure Investors
March 10, 2025 12:16 PM AEDT| By Team Kalkine MediaHighlights,PolyNovo,(PNV) shares rebound following governance updates,Board implements workplace training and succession planning,Former Westpac chair Lindsay,Maxsted,brought in for governance advisory,PolyNovo (ASX:PNV) saw a sharp uptick in its sha...
Polynovo Shares Continue to Decline Following CEO Departure
March 10, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Polynovo faces leadership change amid corporate governance issues.,Botanix sees growth in US pharmaceutical sales, boosting its market position.,EZZ secures a US partner for manufacturing dietary supplements, expanding its market reach.,Po...
Advertise your brand on Kalkine Media